{"name":"Stoke Therapeutics, Inc","slug":"stoke-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":184420000,"revenueGrowth":404.5,"grossMargin":0,"rdSpend":137922000,"netIncome":-6885000,"cash":84220000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2025"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"STK-001 - Single Ascending Doses","genericName":"STK-001 - Single Ascending Doses","slug":"stk-001-single-ascending-doses","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"STK-001 - Single Ascending Doses","genericName":"STK-001 - Single Ascending Doses","slug":"stk-001-single-ascending-doses","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"date":"2026-04-07","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-03-27","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxQQlNhQlc1VS0zOGpXTlA4dWJkeXFBNjkzTm15OXRyallWcnlqYmItV096b1hDbVlaRzVNcjNlcWZDQS1hamd6QmkxXzk3cHdUTzFyTnQ5cW9mdWt2NndrSkFVdW1qdUNpWXI2UjcwSTVwSklyYlE0RHU5dFFNLU8yeWpZdklPaW9oSFNrQmlTdTIwdW9kVGhfZ2xGM0JqSE4yejJuS3JWMjdFT0xUckNwbDM4eHFSdkNXNXhjajhQTnFMZ2FVUmw3TlBMeE5SMXRudXZv?oc=5","date":"2026-02-24","type":"pipeline","source":"Business Wire","summary":"Stoke Therapeutics to Present at the TD Cowen 46th Annual Health Care Conference - Business Wire","headline":"Stoke Therapeutics to Present at the TD Cowen 46th Annual Health Care Conference","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1wFBVV95cUxOV1dqM3QxTllNekk5MWVfMktsM2NFZHlXV0plOHdWdWhDX19mTmttQ2JpWTRFb2pxMWR2OHlKQTNYTlp1cUh2b294bXlGX3dFOFZtd09ScFVhejNWMVE3dUdxb2IwZVFNNWNHeHpaZWdRMU9qMlVVSEM0eEpoWFVvenJyTnRsQm9DRlZGVTE2YjRaT0NsT2p2dzRMZE1oOVAwNmlUOW9CU1o2NDRybF9hRVdkb3JEMzhSR05ZLVdvNWtkRWdLcmRmMWNpUk1fUjh4bXhfTUNMNA?oc=5","date":"2026-02-12","type":"pipeline","source":"The Globe and Mail","summary":"Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail","headline":"Wall Street Analysts Are Bullish on Top Healthcare Picks","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-01-13","type":"pipeline","source":"simplywall.st","summary":"High Growth US Tech Stocks To Watch In January 2026 - simplywall.st","headline":"High Growth US Tech Stocks To Watch In January 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5AFBVV95cUxNUzVEZHRzSklVQVN1aG5ITnVTR3dQVnlGVXYxN1I3S09wdUdhS3VJdTFMM2NXTmRELXZBX2FpNC1WSm9HMHlGWnVkWWs4UEZGal9fZTcybW1EV2JiNWczOEprVDlqemwzLU1oMzNTMjd3Tmp4T3pYVmg2dkNqb0lUYWR0NzQ1NTVFLTdDVDNKOEpsVmZLTWtVdkxLTDdtak1tZ2NQV1k0Y1IxT294SGNYbEZBd1Joa0t2RU1QSGtaVWczWFRfalpqN1VOdmJwY0ItQmtOYzhoak5ZdG41bkdEZkwyZ1k?oc=5","date":"2025-11-04","type":"earnings","source":"Business Wire","summary":"Stoke Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates - Business Wire","headline":"Stoke Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxQU0xIVm4zN1FlLTdCNF9MU2h1YzJ6UDVGZk1jLTBfYUlucXpYeHBEcm95cHozVUlRN2J1dUJ0Z3ZWdmVJcFBSZjRZSVRYREswcmFaLU02OUpBd2cwMlJnRHRoODIyM3kyYnVCemJlVmU3eTk0MnBISVh6QzVlN1RwSzd2ZlpQUQ?oc=5","date":"2025-10-06","type":"pipeline","source":"Yahoo Finance","summary":"Stoke Therapeutics Appoints Ian F. Smith as Chief Executive Officer - Yahoo Finance","headline":"Stoke Therapeutics Appoints Ian F. Smith as Chief Executive Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxQUzNGYmNuNVF0S29uaDRoVEt3dmhpVTZBSUU2LUE2MzVEZ1hYSEhYY2xjMmpnaldkR1VsOGM2U0Nta1Z0MnUxc2tNS0xVNERBNjM0Qm00bXBfX3NJcTBqQU1rUENMNFJBMm5kMzhaZFg0Q01wNDdpNGM1Qm9lYlE1cA?oc=5","date":"2025-10-06","type":"pipeline","source":"The Business Journals","summary":"Former Vertex COO named chief executive at Dravet-focused biotech - The Business Journals","headline":"Former Vertex COO named chief executive at Dravet-focused biotech","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAJBVV95cUxQV3p0WXY5ZXdmOG1nQ0hYMFQyVWs2SDhvWjZYNm1XOGRBLXNPdzEtWGo5WTJvSVVRVi1icS05U1hQcUhGRGxGQWxxdF9qejJuWm1BYlRJT2dYaEVmTzkyclRQWllNSmVMSEZheW9TREtoQ05vTzUxQkdSSXE2UFFJOXNHSkNIU0RhU0szNVVTX1FIRU4zU1RLeWh6Q2d1LVZqRmIxNlJUZWFvSWplYWlWTjJoTW5DdnFYXy1Zc01QQzNiZmxSWVRjWU1ZQnFieE1sbDFwZG9JVGhOOVhZelpWM0ZMMXluU2VrdDBEVDliV0RyRmhZblVDREpvVkRhWGdhZTROUWZFaVlhM3FOWWJuRDZXemRkd21Tc2RDOEsxR3BHcW1saEItV1ZvUkxDendudDZBZHFwUlNCRzc2NVBCYmdrMzc?oc=5","date":"2025-08-28","type":"trial","source":"GlobeNewswire","summary":"Antisense Oligonucleotide Therapeutics Clinical Trial - GlobeNewswire","headline":"Antisense Oligonucleotide Therapeutics Clinical Trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxQd0o3TnhUMGZkeEI3YlJyaHlpN0xzOExtLXVlYUs4NUFNT2JsTmMwVkJfc2t4NE1aWkVEQkFiS3FieFFVUlVJTUhCcXZGR3pVNzg3d2UwSFZlS09yZ3VXRjB2b05kQ1E2azV6cjh2a1d6c0VGY1pVdGVubjhrUkhqamQxN18ybnY2cXlHNXBMMFU?oc=5","date":"2025-08-27","type":"earnings","source":"Seeking Alpha","summary":"Stoke Therapeutics: Vulnerable To Profit Taking (NASDAQ:STOK) - Seeking Alpha","headline":"Stoke Therapeutics: Vulnerable To Profit Taking (NASDAQ:STOK)","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-08-15","type":"pipeline","source":"simplywall.st","summary":"Stoke Therapeutics, Inc. (NASDAQ:STOK) Shares Could Be 25% Above Their Intrinsic Value Estimate - simplywall.st","headline":"Stoke Therapeutics, Inc. (NASDAQ:STOK) Shares Could Be 25% Above Their Intrinsic Value Estimate","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxPSFNzd2lxZzktOERtU2RYZ0dRNEdMQnhoNzVZR01UeDVYWGk5SWlaV0x2STlzcEdGUmE2Zk5MOWFzS1JfMGRSS0RIM2FxUUowemJJbEFPdFVocjFuVG9hdFRrNEpPZTZqZjhXeWZlYXpaVXp0SUFlRXBUdVVpWUVybm05eWtueHJYemxOT2czWk9iY3UzcUsxSkxpLW53a3ItdDFUQkZteTFXLUJuWFY4czNhUzQ2ZmhvQXhGV1RzM0VlSnB5Vkpz?oc=5","date":"2025-08-11","type":"trial","source":"Biogen","summary":"Biogen and Stoke Therapeutics Announce First Patient Dosed in Phase 3 EMPEROR Study of Zorevunersen, a Potential Disease-Modifying Treatment for Dravet Syndrome - Biogen","headline":"Biogen and Stoke Therapeutics Announce First Patient Dosed in Phase 3 EMPEROR Study of Zorevunersen, a Potential Disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiaEFVX3lxTE1GQnIxcFRkak9nWm9nNklSWUw4MFhzUDRHM1J3aDZCX2hpeHV5RFY4VVVnZWpQaE16TGY1Q0J6SjloWVZxOV9IXzZVS1MzU0FEN2M3TnFoUmJaSXZCQms3c0lfTVpac0hw?oc=5","date":"2025-07-10","type":"regulatory","source":"MarketBeat","summary":"Stoke Therapeutics (STOK) FDA Approvals, PDUFA Dates & Drug Alerts 2026 $STOK - MarketBeat","headline":"Stoke Therapeutics (STOK) FDA Approvals, PDUFA Dates & Drug Alerts 2026 $STOK","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxPUWRWR051SGVtdzk3ZkZtdWIwUzE4RUtYX3B5WWhFaTZtYTVKSnRlRG5sRXROR05IYTY3LXl0Sm9tQWJIX2s4cW9zaUFnLXY5VlpRS1NvRnkxN0hCc2VMRk9LZHFFQk9OdFNHTXlnUlRwNlc0dmxOdVdxcEpCeVBQY3JnaHhTWlhQQTBHc0F5cE5aTUoxSklXU2R5cjBBX0Roam9aNXB0UHE3eGU5SGc?oc=5","date":"2025-02-18","type":"trial","source":"Fierce Biotech","summary":"Biogen pays Stoke $165M, bagging Dravet prospect to fire up late-phase pipeline - Fierce Biotech","headline":"Biogen pays Stoke $165M, bagging Dravet prospect to fire up late-phase pipeline","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":184420000,"revenuePeriod":"2025-12-31","revenueHistory":[{"value":184420000,"period":"2025-12-31"},{"value":36555000,"period":"2024-12-31"},{"value":8780000,"period":"2023-12-31"},{"value":12405000,"period":"2022-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":137922000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-6885000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":84220000,"cashHistory":[],"totalAssets":418434000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}